Sanibel Captiva Trust Company Inc. Has $1.36 Million Holdings in Aflac Incorporated (NYSE:AFL)

Sanibel Captiva Trust Company Inc. reduced its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 18.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,264 shares of the financial services provider's stock after selling 2,850 shares during the period. Sanibel Captiva Trust Company Inc.'s holdings in Aflac were worth $1,364,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Private Trust Co. NA raised its holdings in shares of Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock valued at $791,000 after purchasing an additional 99 shares in the last quarter. TKG Advisors LLC raised its stake in Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock valued at $2,230,000 after buying an additional 103 shares in the last quarter. Family Legacy Inc. raised its stake in Aflac by 4.3% in the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock valued at $270,000 after buying an additional 107 shares in the last quarter. Ashton Thomas Private Wealth LLC lifted its holdings in Aflac by 1.9% during the 4th quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider's stock worth $613,000 after buying an additional 110 shares during the last quarter. Finally, Titleist Asset Management LLC lifted its stake in Aflac by 3.4% during the fourth quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider's stock worth $344,000 after purchasing an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.

Aflac Trading Up 0.4%

Shares of NYSE:AFL traded up $0.43 during mid-day trading on Thursday, hitting $101.78. The stock had a trading volume of 624,878 shares, compared to its average volume of 2,103,797. The company's 50 day moving average is $104.99 and its 200-day moving average is $105.75. Aflac Incorporated has a 12-month low of $86.46 and a 12-month high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The company has a market cap of $55.03 billion, a PE ratio of 10.60, a P/E/G ratio of 3.24 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion during the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. Aflac's revenue for the quarter was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.66 EPS. On average, sell-side analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were issued a $0.58 dividend. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.28%. Aflac's dividend payout ratio is 36.25%.

Insider Transactions at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director now owns 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the transaction, the director now directly owns 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock valued at $4,304,295 over the last three months. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

AFL has been the topic of a number of research analyst reports. Raymond James cut their price objective on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. UBS Group lifted their target price on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Piper Sandler boosted their target price on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods upped their target price on Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a research report on Wednesday, May 7th. Finally, Wells Fargo & Company lifted their price target on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, Aflac currently has an average rating of "Hold" and a consensus price target of $104.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.